Hemab Therapeutics Holdings, Inc. (COAG)
Biological Products, (No Diagnostic Substances)
Latest Price
$40.11
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
29.10
P/B Ratio
1.38
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7.81M | $286.0M | 50.03% | -- | 2026-06-30 |
| NOVO HOLDINGS A/S | 4.18M | $153.0M | 26.78% | -- | 2026-06-30 |
| FMR LLC | 3.70M | $135.0M | 23.69% | -- | 2026-06-30 |
| Capital International Investors | 3.60M | $132.0M | 23.09% | -- | 2026-06-30 |
| Deep Track Capital, LP | 3.60M | $132.0M | 23.08% | -- | 2026-06-30 |
| Siren, L.L.C. | 2.09M | $76.0M | 13.37% | -- | 2026-06-30 |
| Avoro Capital Advisors LLC | 1.93M | $70.0M | 12.33% | -- | 2026-06-30 |
| Bain Capital Life Sciences Investors, LLC | 1.65M | $60.0M | 10.57% | -- | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.15M | $42.0M | 7.38% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 780.8K | $28.0M | 5.00% | -- | 2026-06-30 |